Product Code: BHL1587SA
“Global Radiotherapy Market: Unprecedented Growth and Technological Advancements Transforming Cancer Treatment Landscape.”
Radiotherapy is the treatment of diseases such as cancer and tumor while using x-rays or similar form of radiation. The market's expansion is driven by factors such as increasing incidence of cancer, continuous technological advancements such as the development of MRI linear accelerators, proton therapy, and the introduction of treatment planning software that integrates with imaging data. These innovations collectively contribute to improved cancer treatment outcomes.
Further, the global expansion of radiotherapy services is bolstered by growing collaborations and partnerships among industry players, cancer treatment centers, and oncology research institutes, further contributing to market growth. Despite these positive trends, challenges such as the high costs associated with obtaining and implementing radiotherapy devices, particularly in emerging countries with insufficient funds and healthcare infrastructure, may limit the adoption of new radiotherapy technologies.
Market Segmentation:
Segmentation 1: by Procedure
- External Beam Radiotherapy
- Internal Beam Radiotherapy
- Systemic Radiotherapy
Segmentation 2: by End-User
- Hospitals
- Independent Radiotherapy Centres
Segmentation 3: by Type
- Product
- Software and Services
Segmentation 4: by Region
- North America
- Europe
- Asia-Pacific
- Rest-of-the-World
Key Questions to be answered:
- What growth opportunities exist for newcomers in the global radiotherapy market?
- Who are the prominent players operating in the global radiotherapy market?
- What strategies are participants likely to employ to enhance their market share in the global radiotherapy market?
- What emerging trends could impact the growth of the global radiotherapy market?
- Which product type segment is expected to demonstrate a high Compound Annual Growth Rate (CAGR) in the future?
- Which application segment is poised to secure a substantial share in the global radiotherapy industry?
- Which region offers lucrative prospects for manufacturers in the radiotherapy market?
Table of Contents
Executive Summary
Scope and Definition
1 Markets
- 1.1 Trends : Current and Future Impact Assessment
- 1.1.1 Trend 1
- 1.1.2 Trend 2
- 1.1.3 Trend 3
- 1.2 Supply Chain Overview
- 1.2.1 Value Chain Analysis
- 1.2.2 Market Map
- 1.3 Research and Development Review
- 1.3.1 Patent Filing Trend (by Country, Company)
- 1.4 Regulatory Landscape
- 1.5 Impact Analysis for Key Global Events- Covid19
- 1.6 Market Dynamics Overview
- 1.6.1 Market Drivers
- 1.6.2 Market Restraints
- 1.6.3 Market Opportunities
2 Application
- 2.1 Application Segmentation
- 2.2 Application Summary
- 2.3 Global Radiotherapy Market (by Procedure)
- 2.3.1 External Beam Radiotherapy
- 2.3.1.1 Image Guided Radiotherapy
- 2.3.1.2 Intensity Modulated Radiotherapy
- 2.3.1.3 3D Conformal Radiotherapy
- 2.3.1.4 Stereotactic Therapy
- 2.3.1.5 Particle Therapy
- 2.3.2 Internal Beam Radiotherapy
- 2.3.2.1 High Dose Rate Brachytherapy
- 2.3.2.2 Low Dose Rate Brachytherapy
- 2.3.2.3 Pulsed Dose Rate Brachytherapy
- 2.3.3 Systemic Radiotherapy
- 2.4 Global Radiotherapy Market (By End-User)
- 2.4.1 Hospitals
- 2.4.2 Independent Radiotherapy Centres
3 Products
- 3.1 Product Segmentation
- 3.2 Product Summary
- 3.3 Global Radiotherapy Market (by Type)
- 3.3.1 Product
- 3.3.2 Software and Services
- 3.4 Global Radiotherapy Market (By Technology)
- 3.4.1 External Beam Radiotherapy
- 3.4.1.1 Linear Accelerations
- 3.4.1.1.1 Conventional Linear Acceleration
- 3.4.1.1.2 Stereotactic Advanced Electron/Cobalt-60 Linear Accelerators
- 3.4.1.1.2.1 Cyberknife
- 3.4.1.1.2.2 Gamma Knife
- 3.4.1.1.2.3 Tomotherapy
- 3.4.1.1.3 MRI Linear Accelerators (MRI Guided Adaptive Radiotherapy)
- 3.4.1.2 Particle Therapy Systems
- 3.4.1.2.1 Cyclotrons
- 3.4.1.2.2 Synchroton
- 3.4.1.2.3 Synchrocyclotrons
- 3.4.1.3 Conventional Cobalt-60 Teletherapy Units
- 3.4.2 Internal Beam Radiotherapy
- 3.4.2.1 Seeds
- 3.4.2.2 Applicators
- 3.4.2.3 Afterloaders
- 3.4.2.4 Intraoperative Radiation Therapy Systems
- 3.4.3 Systemic Radiotherapy
- 3.4.3.1 Iobenguane (1-131)
- 3.4.3.2 Samarium-153
- 3.4.3.3 Rhenium-186
- 3.4.3.4 Other Systemic Radiotherapy Products
4 Regions
- 4.1 Regional Summary
- 4.2 Drivers and Restraints
- 4.3 North America
- 4.3.1 Regional Overview
- 4.3.2 Driving Factors for Market Growth
- 4.3.3 Factors Challenging the Market
- 4.3.4 Application
- 4.3.5 Product
- 4.3.6 U.S.
- 4.3.7 U.S. Radiotherapy Market by Application
- 4.3.8 U.S. Radiotherapy Market by Product
- 4.3.9 Canada
- 4.3.10 Canada Radiotherapy Market by Application
- 4.3.11 Canada Radiotherapy Market by Product
- 4.4 Europe
- 4.4.1 Regional Overview
- 4.4.2 Driving Factors for Market Growth
- 4.4.3 Factors Challenging the Market
- 4.4.4 Application
- 4.4.5 Product
- 4.4.6 France
- 4.4.7 France Radiotherapy Market by Application
- 4.4.8 France Radiotherapy Market by Product
- 4.4.9 Germany
- 4.4.10 Germany Radiotherapy Market by Application
- 4.4.11 Germany Radiotherapy Market by Product
- 4.4.12 U.K.
- 4.4.13 U.K. Radiotherapy Market by Application
- 4.4.14 U.K. Radiotherapy Market by Product
- 4.4.15 Rest of Europe
- 4.4.16 Rest of Europe Radiotherapy Market by Application
- 4.4.17 Rest of Europe Radiotherapy Market by Product
- 4.5 Asia Pacific
- 4.5.1 Regional Overview
- 4.5.2 Driving Factors for Market Growth
- 4.5.3 Factors Challenging the Market
- 4.5.4 Application
- 4.5.5 Product
- 4.5.6 China
- 4.5.7 China Radiotherapy Market by Application
- 4.5.8 China Radiotherapy Market by Product
- 4.5.9 India
- 4.5.10 India Radiotherapy Market by Application
- 4.5.11 India Radiotherapy Market by Product
- 4.5.12 Japan
- 4.5.13 Japan Radiotherapy Market by Application
- 4.5.14 Japan Radiotherapy Market by Product
- 4.5.15 Rest-of-Asia-Pacific
- 4.5.16 Rest-of-Asia-Pacific Radiotherapy Market by Application
- 4.5.17 Rest-of-Asia-Pacific Radiotherapy Market by Product
- 4.6 Rest-of-the-World
- 4.6.1 Regional Overview
- 4.6.2 Driving Factors for Market Growth
- 4.6.3 Factors Challenging the Market
- 4.6.4 Application
- 4.6.5 Product
- 4.6.6 The Middle East and Africa
- 4.6.7 The Middle East and Africa Radiotherapy Market by Application
- 4.6.8 The Middle East and Africa Radiotherapy Market by Product
- 4.6.9 Latin America
- 4.6.10 Latin America Radiotherapy Market by Application
- 4.6.11 Latin America Radiotherapy Market by Product
5 Markets - Competitive Benchmarking & Company Profiles
- 5.1 Next Frontiers…..
- 5.2 Geographic Assessment
- 5.2.1 Siemens Healthineers AG
- 5.2.1.1 Overview
- 5.2.1.2 Top Products / Product Portfolio
- 5.2.1.3 Top Competitors
- 5.2.1.4 Target Customers
- 5.2.1.5 Key Personnel
- 5.2.1.6 Analyst View
- 5.2.1.7 Market Share
- 5.2.2 Elekta
- 5.2.2.1 Overview
- 5.2.2.2 Top Products / Product Portfolio
- 5.2.2.3 Top Competitors
- 5.2.2.4 Target Customers
- 5.2.2.5 Key Personnel
- 5.2.2.6 Analyst View
- 5.2.2.7 Market Share
- 5.2.3 Accuray Incorporated
- 5.2.3.1 Overview
- 5.2.3.2 Top Products / Product Portfolio
- 5.2.3.3 Top Competitors
- 5.2.3.4 Target Customers
- 5.2.3.5 Key Personnel
- 5.2.3.6 Analyst View
- 5.2.3.7 Market Share
- 5.2.4 BrainLab
- 5.2.4.1 Overview
- 5.2.4.2 Top Products / Product Portfolio
- 5.2.4.3 Top Competitors
- 5.2.4.4 Target Customers
- 5.2.4.5 Key Personnel
- 5.2.4.6 Analyst View
- 5.2.4.7 Market Share
- 5.2.5 Becton & Dickinson
- 5.2.5.1 Overview
- 5.2.5.2 Top Products / Product Portfolio
- 5.2.5.3 Top Competitors
- 5.2.5.4 Target Customers
- 5.2.5.5 Key Personnel
- 5.2.5.6 Analyst View
- 5.2.5.7 Market Share
- 5.2.6 Hitachi Ltd
- 5.2.6.1 Overview
- 5.2.6.2 Top Products / Product Portfolio
- 5.2.6.3 Top Competitors
- 5.2.6.4 Target Customers
- 5.2.6.5 Key Personnel
- 5.2.6.6 Analyst View
- 5.2.6.7 Market Share
- 5.2.7 Perspective Therapeutics
- 5.2.7.1 Overview
- 5.2.7.2 Top Products / Product Portfolio
- 5.2.7.3 Top Competitors
- 5.2.7.4 Target Customers
- 5.2.7.5 Key Personnel
- 5.2.7.6 Analyst View
- 5.2.7.7 Market Share
- 5.2.8 Sensus Healthcare
- 5.2.8.1 Overview
- 5.2.8.2 Top Products / Product Portfolio
- 5.2.8.3 Top Competitors
- 5.2.8.4 Target Customers
- 5.2.8.5 Key Personnel
- 5.2.8.6 Analyst View
- 5.2.8.7 Market Share
- 5.2.9 MagnetTx Oncology Solutions Ltd
- 5.2.9.1 Overview
- 5.2.9.2 Top Products / Product Portfolio
- 5.2.9.3 Top Competitors
- 5.2.9.4 Target Customers
- 5.2.9.5 Key Personnel
- 5.2.9.6 Analyst View
- 5.2.9.7 Market Share
- 5.2.10 Optivus Proton Therapy, Inc.
- 5.2.10.1 Overview
- 5.2.10.2 Top Products / Product Portfolio
- 5.2.10.3 Top Competitors
- 5.2.10.4 Target Customers
- 5.2.10.5 Key Personnel
- 5.2.10.6 Analyst View
- 5.2.10.7 Market Share
- 5.2.11 Mevion Medical Systems
- 5.2.11.1 Overview
- 5.2.11.2 Top Products / Product Portfolio
- 5.2.11.3 Top Competitors
- 5.2.11.4 Target Customers
- 5.2.11.5 Key Personnel
- 5.2.11.6 Analyst View
- 5.2.11.7 Market Share
- 5.2.12 ProTom International
- 5.2.12.1 Overview
- 5.2.12.2 Top Products / Product Portfolio
- 5.2.12.3 Top Competitors
- 5.2.12.4 Target Customers
- 5.2.12.5 Key Personnel
- 5.2.12.6 Analyst View
- 5.2.12.7 Market Share
- 5.2.13 Philips
- 5.2.13.1 Overview
- 5.2.13.2 Top Products / Product Portfolio
- 5.2.13.3 Top Competitors
- 5.2.13.4 Target Customers
- 5.2.13.5 Key Personnel
- 5.2.13.6 Analyst View
- 5.2.13.7 Market Share
- 5.2.14 P-Cure
- 5.2.14.1 Overview
- 5.2.14.2 Top Products / Product Portfolio
- 5.2.14.3 Top Competitors
- 5.2.14.4 Target Customers
- 5.2.14.5 Key Personnel
- 5.2.14.6 Analyst View
- 5.2.14.7 Market Share
- 5.2.15 iCAD
- 5.2.15.1 Overview
- 5.2.15.2 Top Products / Product Portfolio
- 5.2.15.3 Top Competitors
- 5.2.15.4 Target Customers
- 5.2.15.5 Key Personnel
- 5.2.15.6 Analyst View
- 5.2.15.7 Market Share
6 Research Methodology
- 6.1 Data Sources
- 6.1.1 Primary Data Sources
- 6.1.2 Secondary Data Sources
- 6.1.3 Data Triangulation
- 6.2 Market Estimation and Forecast